Neovasc Announces New Appointments in Regulatory and Clinical Leadership
July 13, 2021 09:05 ET
|
Neovasc, Inc.
Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs VANCOUVER and MINNEAPOLIS, July 13,...
Neovasc Announces First Patient Enrollment in COSIMA Trial
May 10, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled...
Neovasc Comments on EuroIntervention Article
April 19, 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the journal EuroIntervention has...
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
February 12, 2021 15:34 ET
|
Neovasc, Inc.
VANCOUVER, CANADA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has closed its previously...
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer™
January 15, 2021 16:59 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received a “not-approvable”...
NVCN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Reminds Neovasc Inc. Investors of Important Tuesday Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN
January 03, 2021 16:00 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 03, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between October 10, 2018 and...
NVCN FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important January 5 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NVCN
December 28, 2020 18:50 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between October 10, 2018 and...
DEADLINE ALERT for HPQ, ICPT, and NVCN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 22, 2020 11:30 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A TOP RANKED LAW FIRM, Reminds Neovasc Inc. Investors of Important January 5 Deadline in Securities Class Action – NVCN
December 17, 2020 18:18 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between October 10, 2018 and...
DEADLINE ALERT for HPQ, ICPT, and NVCN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 10, 2020 11:15 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...